AMR Co. (NYSE: AMR), United Continental (NYSE: UAL), Nuveen PA Investment Quality Municipal Fund (NYSE: NQP), Spirit Airlines Incorporated (NASDAQ: SAVE), Allegiant Travel (NASDAQ: ALGT) and Alaska Air (NYSE: ALK) getting new coverage from analysts.
Maxim Group initiated coverage on AMR Co. (AMR). They placed a “Hold” rating on the company.
Maxim Group initiated coverage on United Continental (NYSE: UAL). They placed a “Buy” rating and a price target of $28.00 on the company.
Stifel Nicolaus initiated coverage on Nuveen PA Investment Quality Municipal Fund (NQP). They placed a “Hold” rating on the company.
Maxim Group initiated coverage on Spirit Airlines Incorporated (SAVE) is now covered by analysts at . They placed a “Buy” rating and a price target of $20.00 on the company.
Maxim Group initiated coverage on Allegiant Travel (ALGT). They placed a “Buy” rating and a price target of $60.00 on the company.
Maxim Group initiated coverage on Alaska Air (ALK). They placed a “Buy” rating and a price target of $86.00 on the company.
Showing posts with label Allegiant Travel. Show all posts
Showing posts with label Allegiant Travel. Show all posts
Tuesday, November 15, 2011
Wednesday, August 3, 2011
MedAssets (MDAS) (HUM) (SNCR) (DLR) (FRO) (ARIA) (ALGT) (CPLP) (GEVO) Price Targets Changed
MedAssets, Inc. (NASDAQ: MDAS), Humana (NYSE: HUM), Synchronoss Technologies, Inc. (NASDAQ: SNCR), Digital Realty Trust, Inc. (NYSE: DLR), Frontline Ltd. (NYSE: FRO), Ariad Pharmaceutical (NASDAQ: ARIA), Allegiant Travel (NASDAQ: ALGT), Capital Product Partners L.P. (NASDAQ: CPLP) and Gevo, Inc. (NASDAQ: GEVO) price targets adjusted by analysts.
MedAssets, Inc. (MDAS) had its price target lowered by UBS AG (NYSE:UBS) from $15.50 to $13.00. The have a “Neutral” rating on the company.
Humana (NYSE: HUM) had its price target raised by Barclays Capital from $85.00 to $90.00. They have an “Equal Weight” rating on the company.
Synchronoss Technologies, Inc. (SNCR) had its price target raised by Stifel Nicolaus from $38.00 to $44.00. They have a “Buy” rating on the company.
Digital Realty Trust, Inc. (DLR) had its price target lowered by Barclays Capital from $70.00 to $67.00. They have an “Overweight” rating on the company.
Frontline Ltd. (FRO) had its price target lowered by Deutsche Bank (NYSE:DB) from $22.00 to $16.00. They have a “Buy” rating on the company.
Ariad Pharmaceutical (ARIA) had its price target raised by Brean Murray from $11.00 to $15.00. They have a “Buy” rating on the company.
Allegiant Travel (ALGT) had its price target cut by Barclays Capital from $65.00 to $61.00. They have an “Overweight” rating on the company.
Capital Product Partners L.P. (CPLP) had its price target lowered by Deutsche Bank from $9.00 to $8.00. They have a “Hold” rating on the company.
Gevo, Inc. (GEVO) had its price target boosted by UBS AG from $21.00 to $23.00. They have a “Buy” rating on the company.
MedAssets, Inc. (MDAS) had its price target lowered by UBS AG (NYSE:UBS) from $15.50 to $13.00. The have a “Neutral” rating on the company.
Humana (NYSE: HUM) had its price target raised by Barclays Capital from $85.00 to $90.00. They have an “Equal Weight” rating on the company.
Synchronoss Technologies, Inc. (SNCR) had its price target raised by Stifel Nicolaus from $38.00 to $44.00. They have a “Buy” rating on the company.
Digital Realty Trust, Inc. (DLR) had its price target lowered by Barclays Capital from $70.00 to $67.00. They have an “Overweight” rating on the company.
Frontline Ltd. (FRO) had its price target lowered by Deutsche Bank (NYSE:DB) from $22.00 to $16.00. They have a “Buy” rating on the company.
Ariad Pharmaceutical (ARIA) had its price target raised by Brean Murray from $11.00 to $15.00. They have a “Buy” rating on the company.
Allegiant Travel (ALGT) had its price target cut by Barclays Capital from $65.00 to $61.00. They have an “Overweight” rating on the company.
Capital Product Partners L.P. (CPLP) had its price target lowered by Deutsche Bank from $9.00 to $8.00. They have a “Hold” rating on the company.
Gevo, Inc. (GEVO) had its price target boosted by UBS AG from $21.00 to $23.00. They have a “Buy” rating on the company.
Subscribe to:
Posts (Atom)